Christopher Dinsmore - Feb 15, 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Scientific Officer
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Stock symbol
KRON
Transactions as of
Feb 15, 2023
Transactions value $
$0
Form type
4
Date filed
2/17/2023, 03:21 PM
Previous filing
Dec 14, 2022
Next filing
Feb 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Award $0 +120K +69.94% $0.00 291K Feb 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Employee Stock Option (Right to Buy) Award $0 +180K $0.00 180K Feb 15, 2023 Common Stock 180K $2.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 8,474 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on the following dates: 959 shares on June 30, 2021, 1,039 shares on December 31, 2021 and 6,476 shares on December 30, 2022.
F2 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.